Private startupCompany profile · informational
Altos Labs
Altos Labs studies cellular rejuvenation — resetting aspects of cell state to restore health and resilience. It has research sites in the San Francisco Bay Area, San Diego and Cambridge, UK, and has not publicly disclosed clinical programs.
Verified highlights each with its source
- Altos Labs launched on Jan. 19, 2022 with $3 billion in committed capital (company release).
Source: prnewswire.com ↗ - The company lists its Bay Area headquarters in Redwood City, California, with additional sites in San Diego and Cambridge, UK.
Source: altoslabs.com ↗
Sources
- en.wikipedia.orgen.wikipedia.org
- altoslabs.comaltoslabs.com
Science and stocks are different questions. This profile describes scientific and regulatory progress. It says nothing about whether the company’s shares will rise or fall, and it is not a recommendation to buy, sell or hold any security.
Disclosure. Spin Pharma has no financial relationship with this company and holds no position in it.
